Also listed on GBS Global Biopharma, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Oct 23, 2038 · High confidence
20-year base term ends Oct 10, 2037
Held by GB Sciences, Inc.
Filed Oct 10, 2017 as application 15/729,565 · Granted May 19, 2020
Base term plus 378 days of patent term adjustment (USPTO delay)
Today
2017
2038
Clock starts
Oct 10, 2017
Oct 10, 2017
Term ends
Oct 23, 2038
Oct 23, 2038
Granted
May 19, 2020
May 19, 2020
base term
patent term adjustment
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
378
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 378 days past its 20-year base term on prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 10, 2017, when this application, 15/729,565, was filed | Oct 10, 2037 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +378 days, USPTO patent term adjustment record | Oct 23, 2038 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 23, 2038 | High confidence |
This family
| US 10,653,640 | this patent Oct 2038 | Oct 2038 |
| US 11,980,592 | In force Apr 2038 | Apr 2038 |
| Application 18/663,034 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 2, 2018 Reel 47039, frame 206 | Small-howard, Andrea; Turner, Helen | Growblox Life Sciences L.L.C. | Assignment of Assignor's Interest |
| Mar 22, 2019 Reel 48676, frame 815 | Growblox Life Sciences LLC | GBS Global Biopharma, Inc. | Assignment of Assignor's Interest |
| Sep 6, 2024 Reel 68507, frame 757 | GBS Global Biopharma, Inc. | GB Sciences, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Oct 2038
Term ends Oct 23, 2038. Maintenance fees still fall due before then
Note
The 378 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
1
later US patent cites this one
That is below the median of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.